摘要
早产儿视网膜病变(retinopathy of prematurity,ROP)是一种未成熟或低体重出生婴儿的增生性视网膜病变,目前国内临床上治疗主要是冷冻治疗和激光光凝,近年来药物性治疗及基础研究已有一些报道,本文对贝伐单抗、雷珠单抗及其他几个研究性药物治疗ROP研究新进展进行综述。
Retinopathy of prematurity （ ROP） is a vasoproliferative retinopathy with unmatured and low weight infants. Now in domestic, the main treatment methods are cryotherapy and laser coagulation, there are some medication treatment researches and fundamental researches that have been reported in recent years.This review describes the application of bevacizumab, ranibizumab and other research-based drugs in new progress of the treatment study for ROP.
出处
《国际眼科杂志》
CAS
2014年第3期460-463,共4页
International Eye Science
关键词
早产儿视网膜病变
血管内皮细胞生长因子
药物治疗
剂量
实验研究
retinopathy of prematurity
vascular endothelial growth factor
medication treatment
dosage
experimental study
